Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis

Journal of Rheumatology

Volumn 41, Issue 6, 2014, Pages 1049-1060

  Shea, Beverley ^a   Swinden, Michael V ^a   Ghogomu, Elizabeth Tanjong ^a   Ortiz, Zulma ^b   Katchamart, Wanruchada ^c   Rader, Tamara ^d   Bombardier, Claire ^e   Wells, George A ^a   Tugwell, Peter ^f,g  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Musculoskeletal Group   (Canada)

^e INSTITUTE FOR WORK AND HEALTH   (Canada)

^f Institute of Population Health   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cochrane review; Folic acid; Folinic acid; Rheumatoid arthritis

Indexed keywords

FOLIC ACID; FOLINIC ACID; METHOTREXATE; PLACEBO; ANTIRHEUMATIC AGENT;

ABDOMINAL PAIN; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTHRALGIA; CYTOPENIA; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; JOINT SWELLING; LIVER DYSFUNCTION; LIVER TOXICITY; LOW DRUG DOSE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; STOMATITIS; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; VOMITING; ADULT; ARTHRITIS, RHEUMATOID; FEMALE; MALE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FOLIC ACID; HUMANS; LEUCOVORIN; MALE; METHOTREXATE;

EID: 84901712332     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130738     Document Type: Review

References (31)

1. Kremer J. The changing face of therapy for rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:845-52.
2. Felson D, Anderson J, Meenan R. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two meta-analyses. Arthritis Rheum 1990;33:1449-61. (Pubitemid 20362087)
3. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2000;(2):CD000957.
4. Tugwell P, Bennett K, Gent M. Methotrexate in rheumatoid arthritis. Ann Intern Med 1987;107:358-66.
5. Schnabel A, Gross WL. Low-dose methotrexate in rheumatic diseases - efficacy, side effects, and risk factors for side effects. Semin Arthritis Rheum 1994;23:310-27. (Pubitemid 24116664)
6. Leeb BF, Witzmann G, Ogris E, Studnicka-Benke A, Andel I, Schweitzer H, et al. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol 1995;13:459-63.
7. Griffith S, Fisher J, Clarke S, Montgomery B, Jones P, Saklatvala J, et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term? Rheumatology 2000;39:1102-9.
8. Joyce D, Will D, Hoffman D, Laing B, Blackbourn S. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann Rheum Dis 1991;50:913-4.
9. Tishler M, Caspi D, Fishel B, Yaron M. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum 1988;31:906-8.
10. Arnett F, Edworthy S, Bloch D, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
11. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. [Internet. Accessed March 5, 2014.] Available from: www.cochrane-handbook. org
12. Chakravarty K, McDonald H, Pullar T, Taggart A, Chalmers R, Oliver S, et al. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology 2008;47:924-5.
13. Dutch Society of Rheumatology. Guidelines for medication: methotrexate ID - 52, 2009 [in Dutch]. [Internet. Accessed March 5, 2014.] Available from: www.nvrnl/richtlijnen/Totstandkoming-richtlijnen
14. GUIPCAR Group. Clinical practice guideline for the management of rheumatoid arthritis in Spain, ID - 54. Madrid: Spanish Society of Rheumatology;2007.
15. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 Update of the 2008 American College of Rheumatology Recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012;64:625-39.
16. Higgins J, Altman D. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. [Internet. Accessed March 5, 2014.] Available from: www.cochrane-handbook.org
17. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. [Internet. Accessed March 5, 2014.] Available from: www.cochrane-handbook. org
18. Schünemann HJ, Oxman AD, Vist G, Higgins J, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. [Internet. Accessed March 5, 2014.] Available from: www.cochrane-handbook.org
19. Buckley L, Vacek P, Cooper S. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. J Rheumatol 1990;17:1158-61. (Pubitemid 20334691)
20. Morgan SL, Baggott J, Vaughn W, Young P, Austin J, Krumdieck C, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1990;33:9-18. (Pubitemid 20040125)
21. Morgan SL, Baggot JE, Vaughn WH, Austin JS, Veitch JA, Lee JY, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo controlled trial. Ann Intern Med 1994;121:833-41.
22. Shiroky JB, Neville C, Esdaile JM, Choquette D, Zummer M, Hazeltine M, et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo- controlled trial. Arthritis Rheum 1993;36:795-803. (Pubitemid 23175621)
23. Van Ede A, Laan R, Blom H, Huizinga T, Haagsma C, Giesendorf B, et al. The C677T mutation in the methylenetetrahydrofolate reductase gene. A genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum 2001;44:2525-30. (Pubitemid 33049330)
24. Weinblatt ME, Maier AL, Coblyn JS. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. J Rheumatol 1993;20:950-2. (Pubitemid 23203232)
25. Methotrexate - clinical pharmacology (updated 2013). [Internet. Accessed March 31, 2014.] Available from: www.drugs.com/pro/methotrexate.html
26. Dijkmans B. Folate supplementation and methotrexate. Br J Rheumatol 1995;34:1172-4. (Pubitemid 26055340)
27. Furst DE, Clements PJ. Pharmacologic approaches. SAARDs II. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby; 1994:section 8, chapter 13, pp.1-8.
28. Drummond M, Bosi Ferraz M, Mason J. Assessing the cost effectiveness of NSAID: an international perspective. J Rheumatol 1995;22:1408-14.
29. Morgan S, Alarcón G, Krumdieck C. Folic acid supplementation during methotrexate therapy: it makes sense (editorial). J Rheumatol 1993;20:929-30. (Pubitemid 23203227)
30. Salach R, Cash J. Methotrexate: The emerging drug of choice for serious rheumatoid arthritis. Clin Ther 1994;16:912-22.
31. Hartman M, van Ede AE, Severens JL, Laan RF, van de Putte L, van der Wilt GJ. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. J Rheumatol 2004;31:902-8. (Pubitemid 38585812)